Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • CARDIAC SCIENCE CORP Financial Overview

  • Income Statement: CSCX

      2008 2007 Change ( 2007 - 2008  )
    Net Sales/Revenues 206.15 M 182.13 M 24.02 M 11.65%
    Gross Profit 103.49 M 88.42 M 15.07 M 14.56%
    Net Income Before Extra Items/Preferred Div -98.38 M 8.49 M -106.87 M 108.63%
    Operating Income 13.91 M 10.02 M 3.88 M 27.93%
  • Cash Flow: CSCX

      2008 2007 Change ( 2007 - 2008  )
    Net Cash Flow - Financing 859,000.00 780,000.00 79,000.00 9.20%
    Net Cash Flow - Investing 4.35 M 3.79 M 564,000.00 12.96%
    Net Cash Flow/Operating Activities 17.74 M 13.35 M 4.40 M 24.77%
  • Balance Sheet: CSCX

      2008 2007 Change ( 2007 - 2008  )
    Total Assets 141.76 M 232.38 M -90.63 M -63.93%
    Total Liabilities 9.51 M 4.98 M 4.52 M 47.57%
    Shareholders Equity 131.70 M 227.27 M -95.57 M -72.56%
  • Key Ratios / Statistics: CSCX

    • Valuation

      Price/Earnings (TTM) -1.74
      Price/Sales (TTM) 0.83
      Price/Book (MRQ) 0.71
      Price/Cash Flow (TTM) 7.07
    • Profitability

      Gross Margin 50.20
      Operating Margin 6.75
      Profit Margin -47.72
    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00
    • Financial Strength

      Quick Ratio (MRQ) 1.75
      Current Ratio (MRQ) 2.86
      Long Term Debt-to-Equity (MRQ) 0.00
    • Management Effectiveness

      Return on Equity (TTM) -55.57
      Return on Assets (TTM) -52.59
      Return on Investments (TTM) -54.71